Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life. RSD [Internet]. 2025 May 14 [cited 2026 Apr. 2];14(5):e4914548812. Available from: https://www.rsdjournal.org/rsd/article/view/48812